<DOC>
<DOCNO>
EP-0013568
</DOCNO>
<TEXT>
<DATE>
19800723
</DATE>
<IPC-CLASSIFICATIONS>
C07K-14/62 C07K-1/113 C07K-14/435 C07K-1/00 C07K-14/575 A61P-5/00 A61K-38/28 
</IPC-CLASSIFICATIONS>
<TITLE>
sulfonated insulines and process for their preparation.
</TITLE>
<APPLICANT>
hoechst agde<sep>hoechst aktiengesellschaft<sep>hoechst aktiengesellschaft65926 frankfurt am mainde<sep>
</APPLICANT>
<INVENTOR>
geiger rolf drde<sep>geisen karl drde<sep>neubauer horst drde<sep>regitz guenter dr de <sep>summ hans-dieter drde<sep>geiger, rolf, dr.<sep>geisen, karl, dr.<sep>neubauer, horst, dr.<sep>regitz, guenter, dr.<sep>summ, hans-dieter, dr.<sep>geiger, rolf, dr.heinrich-bleicher-strasse 33d-6000 frankfurt am main 50de<sep>geisen, karl, dr.jahnstrasse 43d-6000 frankfurt am mainde<sep>neubauer, horst, dr.am eichkopf 12d-6240 königstein/taunusde<sep>regitz, günter, dr.dachbergstrasse 68d-6232 bad soden am taunusde<sep>summ, hans-dieter, dr.heimchenweg 48d-6230 frankfurt am main 80de<sep>
</INVENTOR>
<ABSTRACT>
the insulin derivatives have the general formula i   <image> in which x is an alkanoyl or cycloalkanoyl radical which has 2-10 c atoms and carries a sulpho group and which optionally also contains carboxamide, urethane, hydroxyl or carboxyl groups, and are prepared by reacting n< alpha (a1)>, n< epsilon (b29)>-ditert-butyloxycarbonylinsulin with an excess of an activated derivative of a carboxylic acid x-oh, and treating the reaction product with a strong acid. 
</ABSTRACT>
</TEXT>
</DOC>
